Thomas Klopstock
Ludwig-Maximilians-Universität München
H-index: 88
Europe-Germany
Top articles of Thomas Klopstock
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial | Cell Reports Medicine | Patrick Yu-Wai-Man Valerio Carelli Nancy J Newman Magda Joana Silva Aki Linden | 2024/2/29 |
Natural history of mitochondrial optic neuropathies | Acta Ophthalmologica | Thomas Klopstock | 2024/1 |
Management of seizures in patients with primary mitochondrial diseases: consensus statement from the InterERNs Mitochondrial Working Group | European Journal of Neurology | Michelangelo Mancuso Maria T Papadopoulou Yi Shiau Ng Anna Ardissone Marcello Bellusci | 2024/4/4 |
Genetic variants affecting NQO1 protein levels impact the efficacy of idebenone treatment in Leber hereditary optic neuropathy | Cell Reports Medicine | Serena Jasmine Aleo Valentina Del Dotto Martina Romagnoli Claudio Fiorini Giada Capirossi | 2024/2/20 |
Phenotype and natural history of mitochondrial membrane protein-associated neurodegeneration | Brain | Vassilena Iankova Peter Sparber Mohammad Rohani Petr Dusek Boriana Büchner | 2024/4 |
New insights into idebenone therapy in relation to NQO1 | Acta Ophthalmologica | Chiara La Morgia Serena Jasmine Aleo Valentina Del Dotto Martina Romagnoli Claudio Fiorini | 2024/1 |
Recommendations for optimal interdisciplinary management and healthcare settings for patients with rare neurological diseases | Orphanet Journal of Rare Diseases | Holm Graessner Carola Reinhard Tobias Bäumer Annette Baumgärtner Knut Brockmann | 2024/2/13 |
FARS‐ADL across Ataxias: Construct Validity, Sensitivity to Change, and Minimal Important Change | Movement Disorders | Andreas Traschütz Zofia Fleszar Holger Hengel Thomas Klockgether Friedrich Erdlenbruch | 2024/3/20 |
Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting–a 12-month multicenter cohort study from the German early access program | Eclinicalmedicine | Maximilian Wiesenfarth Johannes Dorst David Brenner Zeynep Elmas Özlem Parlak | 2024/3/1 |
Current management of primary mitochondrial disorders in EU countries: the European Reference Networks survey | Journal of Neurology | Michelangelo Mancuso Piervito Lopriore Costanza Lamperti Thomas Klopstock Shamima Rahman | 2024/2 |
A GGC-repeat expansion in ZFHX3 encoding polyglycine causes spinocerebellar ataxia type 4 and impairs autophagy | Nature Genetics | Karla P Figueroa Caspar Gross Elena Buena-Atienza Sharan Paul Mandi Gandelman | 2024/4/29 |
Predictors of Survival in Friedreich's Ataxia: A Prospective Cohort Study | Movement Disorders | Elisabetta Indelicato Kathrin Reetz Sarah Maier Wolfgang Nachbauer Matthias Amprosi | 2024/3 |
Long‐term efficacy of idebenone in patients with Leber hereditary optic neuropathy according to age at symptom onset and disease phase: Results from the LEROS study | Acta Ophthalmologica | Xavier Llòria Patrick Yu‐Wai‐Man Valerio Carelli Livia Tomasso Thomas Klopstock | 2024/1 |
Assessing Clinically Relevant Recovery of Visual Acuity Over Time in Patients with Leber Hereditary Optic Neuropathy Treated with Idebenone: Results from the LEROS Study (S40. 001) | Nancy Newman Patrick Yu-Wai-Man Valerio Carelli Xavier Llòria Thomas Klopstock | 2024/4/14 | |
Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias | The American Journal of Human Genetics | Paulina Cunha Emilien Petit Marie Coutelier Giulia Coarelli Caterina Mariotti | 2023/7/6 |
Treatment with lenadogene nolparvovec gene therapy results in sustained visual improvement in m. 11778G> A MT-ND4-LHON patients: the RESTORE study | Investigative Ophthalmology & Visual Science | Patrick Yu-Wai-Man Nancy J Newman Biousse Valérie Valerio Carelli Mark L Moster | 2023/6/1 |
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey | Orphanet Journal of Rare Diseases | Thomas Klopstock Saadet Mercimek-Andrews Agnieszka Jurecka Patricia Wood Maciej Cwyl | 2023/8/31 |
Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset | Annals of Clinical and Translational Neurology | Luca Porcu Mario Fichera Lorenzo Nanetti Eliana Rulli Paola Giunti | 2023/11 |
Protocol: Patient-reported, health economic and psychosocial outcomes in patients with Friedreich ataxia (PROFA): protocol of an observational study using momentary data … | BMJ Open | Maresa Buchholz Niklas Weber Stephanie Borel Sabrina Sayah Feng Xie | 2023 |
Long-term Follow-up of m. 11778G> A MT-ND4-LHON Patients Treated with Lenadogene Nolparvovec Ocular Gene Therapy: the RESTORE Study (S12. 004) | Valerie Biousse Nancy Newman Patrick Yu-Wai-Man Valerio Carelli Mark Moster | 2023/4/25 |
